Sign Up
OverviewAPI
The U.S. molecular diagnostics market is projected to reach USD 9.78 billion by 2032, driven by increasing prevalence of infections and technological advancements. The global COVID-19 sample collection kits market is expected to reach USD 1.26 billion by 2030, fueled by the demand for testing materials and regulatory support. The global respiratory syncytial virus market is projected to reach USD 2.2 billion in 2030, driven by rising sickness rates and advancements in detection procedures.

Ask a question